MortierS., LameireN.H., De VrieseA.S.Animal models in peritoneal dialysis research: A need for consensus.Perit Dial Int2005; 25: 16–24.
2.
ZareieM., van LambalgenA.A., ter WeeP.M., HekkingL.H.P., KeuningE.D., Schadee-EestermansI.L.Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.Perit Dial Int2005; 25: 58–67.
3.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
4.
De VrieseA.S., MortierS., CornelissenM., PalmansE., VanackerN.J., LeyssensA.The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure.Perit Dial Int2002; 22: 566–72.
5.
De VrieseA.S., FlyvbjergA., MortierS., TiltonR.G., LameireN.H.Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane.J Am Soc Nephrol2003; 14: 2109–18.
6.
HekkingL.H., ZareieM., DriesprongB.A., FaictD., WeltenA.G., de GreeuwI.Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.J Am Soc Nephrol2001; 12: 2775–86.
7.
MortierS., De VrieseA.S., LeyssensA., VanackerN.J., FaictD., CornelissenM.Antibiotic administration in an animal model of chronic peritoneal dialysate exposure.Perit Dial Int2003; 23: 331–8.
8.
MortierS., De VrieseA.S., McLoughlinR.M., TopleyN., SchaubT.P., Passlick-DeetjenJ.Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.J Am Soc Nephrol2003; 14: 1296–306.
9.
MusiB., BraideM., CarlssonO., WieslanderA., AlbrektssonA., KettelerM.Biocompatibility of peritoneal dialysis fluids: Long-term exposure of nonuremic rats.Perit Dial Int2004; 24: 37–47.
10.
NishinoT., MiyazakiM., AbeK., FurusuA., MishimaY., HaradaT.Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats.Kidney Int2003; 64: 887–96.
11.
ZareieM., HekkingL.H., WeltenA.G., DriesprongB.A., Schadee-EestermansI.L., FaictD.Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.Nephrol Dial Transplant2003; 18: 2629–37.
12.
ZareieM., KeuningE.D., ter WeeP.M., BeelenR.H., van den BornJ.Improvement of a chronic rat model for peritoneal dialysis by using heparin-coated catheters.Adv Perit Dial2004; 20: 150–4.
13.
ZweersM.M., SplintL.J., KredietR.T., StruijkD.G.Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat.Nephrol Dial Transplant2001; 16: 651–4.
14.
MargettsP.J., KolbM., YuL., HoffC.M., HolmesC.J., AnthonyD.C.Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.Am J Pathol2002; 160: 2285–94.
15.
MargettsP.J., GyorffyS., KolbM., YuL., HoffC.M., HolmesC.J.Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.J Am Soc Nephrol2002; 13: 721–8.
16.
MargettsP.J., KolbM., GaltT., HoffC.M., ShockleyT.R., GauldieJ.Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function.J Am Soc Nephrol2001; 12: 2029–39.
17.
WilliamsJ.D., CraigK.J., TopleyN., WilliamsG.T.Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions.Kidney Int Suppl2003; 84: 158–61.
18.
WilliamsJ.D., CraigK.J., von RuhlandC., TopleyN., WilliamsG.T.The natural course of peritoneal membrane biology during peritoneal dialysis.Kidney Int Suppl2003; 88: S43–9.
